PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#galantamine ×

UPDATED
Regulatory Updates
Aug 30, 2026•1 min read
FDA Approves Zydus Generic Galantamine Hydrobromide Tablets (ANDA078898)
FDA has approved ANDA078898 for Zydus Pharm's oral galantamine hydrobromide tablets (4 mg, 8 mg, 12 mg) with standard labeling submissions.